ResMed Inc (BSP:R1MD34)
R$ 368.7 0.14 (0.04%) Market Cap: 216.49 Bil Enterprise Value: 218.91 Bil PE Ratio: 32.69 PB Ratio: 6.97 GF Score: 87/100

Q3 2024 Resmed Inc Earnings Call Transcript

Apr 25, 2024 / 08:30PM GMT
Release Date Price: R$235.92 (-0.46%)
Operator

Hello, and welcome to the Q3 Fiscal Year 2024 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being recorded.

I'll now turn the call over to Amy Wakeham, Chief Investor Relations Officer. Amy, you may begin.

Amy Wakeham
ResMed Inc. - Chief IR Officer

Great. Thank you, Kevin. Hello, everyone. Welcome to ResMed's Third Quarter Fiscal Year 2024 Earnings Call. We are live webcasting this call, and the replay will be available on the Investor Relations section of our corporate website later today. Our earnings press release and presentation are both available online now.

During today's call, we will discuss several non-GAAP measures that we believe provide useful information for investors. This information is not intended to be considered in isolation or as a substitute for the GAAP financial information. We encourage you to review the supporting schedules in today's earnings press release to reconcile the non-GAAP measures with the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot